2nd Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy
The European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA) are pleased to announce the 2nd Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy.
Capitalizing on the success of the 1st and 2nd editions of the Joint EBMT-EHA EU Meeting on CAR T-Cells held in Paris, France in February 2019 and Sitges, Spain 2020, and the first virtual edition on 2021, the two professional associations will team up again in 2022 to bring the 4th edition of the same meeting, now as a hybrid meeting. The meeting will again bring together prestigious keynote lecturers from the USA, China and Europe, senior and junior investigators interested in preclinical and clinical development of this new class of innovative therapies, all categories of healthcare professionals involved in the safe administration and delivery of CAR-T cells, and representatives of all stakeholders including patients advocates and representatives. The meeting is meant to foster interactions among delegates, and favour the development of collaborative projects across Europe and with investigators from other parts of the world.
During the meeting, EBMT and EHA will jointly award 3 of 10,000 € prizes to support emerging researchers’ groups involved in the preclinical or clinical development of CAR T-Cell therapies or IEC based therapies at large. The awardees will be selected among abstract submitters who have indicated their interest in applying for the award, and will be selected for an oral presentation during one of the two flash-talk sessions.
The winner will be requested to send a report on the status and progress of the project for the 5th CART meeting in 2023 (extended abstract).
The Award can only be used for the professional support of the research group as such. Personal allowances are excluded.
How to Apply
Through the abstract submission platform at https://cart2022.abstractserver.com/submission/
If the abstract submitter is interested in applying for the award, they would need to check yes when asked “Do you wish to be considered for the Emerging Investigators EHA-EBMT Joint Fellowship Award in the Field of Cell Therapy and Immunotherapy 2022?”
Following the abstract review, the SPC members will make a pre-selection of the best scored abstracts that have indicated that they are interested in applying for the award.
The EBMT office will then contact the pre-selected abstract authors by 17 December 2021, and request that they submit the following accompanying documentation to apply for the award:
- Name, address, affiliation of the research group / team / lab
- Principal Investigator’s CV
- Motivation letter (minimum 200 words)
- List of the most important publications
- Synopsis of the research project (maximum 1000 words)
First deadline to indicate interest in applying: 30th November 2021 23:59 CET
(must be done at the time of abstract submission, in the submission platform)
Second deadline to submit accompanying documents: January 9, 2022 23:59 CET